Mark A. Pallansch
#138,662
Most Influential Person Now
Researcher
Mark A. Pallansch's AcademicInfluence.com Rankings
Mark A. Pallanschcomputer-science Degrees
Computer Science
#6523
World Rank
#6876
Historical Rank
Computational Linguistics
#1144
World Rank
#1158
Historical Rank
Machine Learning
#2147
World Rank
#2175
Historical Rank
Artificial Intelligence
#2409
World Rank
#2450
Historical Rank
Download Badge
Computer Science
Mark A. Pallansch's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Mark A. Pallansch Influential?
(Suggest an Edit or Addition)Mark A. Pallansch's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- First Case of 2019 Novel Coronavirus in the United States (2020) (5157)
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome (2003) (2442)
- Molecular Evolution of the Human Enteroviruses: Correlation of Serotype with VP1 Sequence and Application to Picornavirus Classification (1999) (786)
- Sensitive, Seminested PCR Amplification of VP1 Sequences for Direct Identification of All Enterovirus Serotypes from Original Clinical Specimens (2006) (776)
- Vaccine-derived polioviruses and the endgame strategy for global polio eradication. (2005) (652)
- Enterovirus surveillance--United States, 1970-2005. (2006) (646)
- Outbreak of Poliomyelitis in Hispaniola Associated with Circulating Type 1 Vaccine-Derived Poliovirus (2002) (556)
- Typing of Human Enteroviruses by Partial Sequencing of VP1 (1999) (533)
- Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. (2000) (513)
- Molecular Epidemiology and Evolution of Enterovirus 71 Strains Isolated from 1970 to 1998 (1999) (424)
- Geographic distribution of wild poliovirus type 1 genotypes. (1987) (339)
- Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak — United States, December 31, 2019–February 4, 2020 (2020) (337)
- Comparison of Classic and Molecular Approaches for the Identification of Untypeable Enteroviruses (2000) (331)
- Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description (2014) (312)
- Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. (1992) (307)
- ICTV Virus Taxonomy Profile: Picornaviridae (2017) (292)
- Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. (2003) (265)
- Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. (2004) (253)
- Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States (2020) (245)
- Enterovirus 71 infections and neurologic disease--United States, 1977-1991. (1994) (245)
- Complete Genomic Sequencing Shows that Polioviruses and Members of Human Enterovirus Species C Are Closely Related in the Noncapsid Coding Region (2003) (242)
- Sensitive and Broadly Reactive Reverse Transcription-PCR Assays To Detect Novel Paramyxoviruses (2008) (241)
- Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. (1995) (234)
- Evidence for Frequent Recombination within Species Human Enterovirus B Based on Complete Genomic Sequences of All Thirty-Seven Serotypes (2004) (230)
- Circulation of Endemic Type 2 Vaccine-Derived Poliovirus in Egypt from 1983 to 1993 (2003) (220)
- Circulating vaccine-derived polioviruses: current state of knowledge. (2004) (219)
- Prolonged Replication of a Type 1 Vaccine-Derived Poliovirus in an Immunodeficient Patient (1998) (210)
- Vaccine policy changes and epidemiology of poliomyelitis in the United States. (2004) (198)
- Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. (2007) (189)
- Species-specific RT-PCR amplification of human enteroviruses: a tool for rapid species identification of uncharacterized enteroviruses. (2006) (187)
- Complete genome sequences of all members of the species Human enterovirus A. (2004) (179)
- Serotype-Specific Identification of Polioviruses by PCR Using Primers Containing Mixed-Base or Deoxyinosine Residues at Positions of Codon Degeneracy (1996) (170)
- Acute Flaccid Myelitis in the United States, August-December 2014: Results of Nationwide Surveillance. (2016) (170)
- Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. (1998) (167)
- Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. (1997) (165)
- Risks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After Eradication (2006) (162)
- Neonatal Enterovirus Infections Reported to the National Enterovirus Surveillance System in the United States, 1983–2003 (2006) (161)
- Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation (2015) (160)
- Detection of All Known Parechoviruses by Real-Time PCR (2008) (158)
- Fractional doses of inactivated poliovirus vaccine in Oman. (2010) (157)
- Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. (1991) (153)
- Enteroviruses 76, 89, 90 and 91 represent a novel group within the species Human enterovirus A. (2005) (147)
- Circulation of Type 1 Vaccine-Derived Poliovirus in the Philippines in 2001 (2004) (143)
- First 12 patients with coronavirus disease 2019 (COVID-19) in the United States (2020) (139)
- RNA Recombination Plays a Major Role in Genomic Change during Circulation of Coxsackie B Viruses (2004) (137)
- Economic analysis of the global polio eradication initiative. (2010) (135)
- Multiple Independent Emergences of Type 2 Vaccine-Derived Polioviruses during a Large Outbreak in Northern Nigeria (2013) (134)
- Molecular identification of new picornaviruses and characterization of a proposed enterovirus 73 serotype. (2001) (134)
- Molecular Epidemiology and Genetic Diversity of Echovirus Type 30 (E30): Genotypes Correlate with Temporal Dynamics of E30 Isolation (1999) (133)
- Protease required for processing picornaviral coat protein resides in the viral replicase gene (1979) (133)
- Polio eradication: the OPV paradox (2003) (132)
- Protein processing map of poliovirus (1984) (129)
- Detection of enteroviruses and rhinoviruses in clinical specimens by PCR and liquid-phase hybridization (1995) (126)
- Outbreak of poliomyelitis‐like paralysis associated with enterovirus 71 (1989) (125)
- Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditis. (1990) (124)
- Comparative study of five methods for intratypic differentiation of polioviruses (1995) (124)
- Molecular identification and characterization of two proposed new enterovirus serotypes, EV74 and EV75. (2004) (123)
- Molecular Evolution of a Type 1 Wild-Vaccine Poliovirus Recombinant during Widespread Circulation in China (2000) (118)
- First Confirmed Cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, Updated Information on the Epidemiology of MERS-CoV Infection, and Guidance for the Public, Clinicians, and Public Health Authorities — May 2014 (2014) (117)
- A molecular and serologic evaluation of enteroviral involvement in human myocarditis. (1990) (114)
- Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom. (2004) (114)
- Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Research Group. (1995) (113)
- The Role of Enteroviral Infections in the Development of IDDM: Limitations of Current Approaches (1997) (112)
- Molecular identification of 13 new enterovirus types, EV79-88, EV97, and EV100-101, members of the species Human Enterovirus B. (2007) (111)
- Prospective study of enteroviral infections and development of beta-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY). (2003) (111)
- Stillbirth During Infection With Middle East Respiratory Syndrome Coronavirus (2014) (110)
- Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. (1993) (110)
- Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005. (2008) (107)
- Outbreak of Type 2 Vaccine-Derived Poliovirus in Nigeria: Emergence and Widespread Circulation in an Underimmunized Population (2011) (107)
- Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children (1991) (107)
- Efficacy of inactivated poliovirus vaccine in India (2014) (103)
- Infant deaths associated with human parechovirus infection in Wisconsin. (2010) (103)
- Expert Review on Poliovirus Immunity and Transmission (2013) (100)
- Complete sequence of echovirus 23 and its relationship to echovirus 22 and other human enteroviruses. (1998) (98)
- Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis. (2003) (98)
- Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial. (2012) (95)
- Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. (1992) (95)
- Oral Poliovirus Vaccine Evolution and Insights Relevant to Modeling the Risks of Circulating Vaccine‐Derived Polioviruses (cVDPVs) (2013) (94)
- Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota. (2009) (92)
- A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future. (2005) (92)
- Poliovirus detection in wastewater and stools following an immunization campaign in Havana, Cuba. (2003) (91)
- Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial. (2015) (89)
- Characterizing Poliovirus Transmission and Evolution: Insights from Modeling Experiences with Wild and Vaccine‐Related Polioviruses (2013) (86)
- Intratypic Recombination among Lineages of Type 1 Vaccine-Derived Poliovirus Emerging during Chronic Infection of an Immunodeficient Patient (2005) (85)
- Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy (1996) (85)
- Resolving ambiguities in genetic typing of human enterovirus species C clinical isolates and identification of enterovirus 96, 99 and 102. (2009) (84)
- Clinical and Laboratory Findings of the First Imported Case of Middle East Respiratory Syndrome Coronavirus to the United States (2014) (84)
- Standardized Methods for Detection of Poliovirus Antibodies. (2016) (83)
- Serial Recombination during Circulation of Type 1 Wild-Vaccine Recombinant Polioviruses in China (2003) (83)
- The eradication of polio--progress and challenges. (2006) (82)
- Cell-free synthesis and processing of the proteins of poliovirus. (1978) (80)
- Characterizing the Picornavirus Landscape among Synanthropic Nonhuman Primates in Bangladesh, 2007 to 2008 (2012) (77)
- Molecular Phylogeny and Proposed Classification of the Simian Picornaviruses (2002) (77)
- Trial of a supplemental dose of four poliovirus vaccines. (2000) (77)
- Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. (1996) (76)
- The risks, costs, and benefits of possible future global policies for managing polioviruses. (2008) (75)
- Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2018–June 2019 (2019) (75)
- Identification of vaccine-related polioviruses by hybridization with specific RNA probes (1995) (75)
- Molecular phylogeny of all human enterovirus serotypes based on comparison of sequences at the 5' end of the region encoding VP2. (1998) (74)
- Genotypic variation in coxsackievirus B5 isolates from three different outbreaks in the United States. (1995) (74)
- Role of enterovirus 71 in acute flaccid paralysis after the eradication of poliovirus in Brazil. (1996) (74)
- Echovirus 22 is an atypical enterovirus (1990) (73)
- Direct detection of wild poliovirus circulation by stool surveys of healthy children and analysis of community wastewater. (1993) (73)
- Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine (2020) (72)
- Parechovirus typing in clinical specimens by nested or semi-nested PCR coupled with sequencing. (2010) (72)
- The seasonality of nonpolio enteroviruses in the United States: Patterns and drivers (2018) (72)
- A large vaccine-derived poliovirus outbreak on Madura Island--Indonesia, 2005. (2008) (70)
- Review and Assessment of Poliovirus Immunity and Transmission: Synthesis of Knowledge Gaps and Identification of Research Needs (2013) (69)
- Resolution of the Pathways of Poliovirus Type 1 Transmission during an Outbreak (2000) (68)
- Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand (2005) (68)
- An economic analysis of poliovirus risk management policy options for 2013–2052 (2015) (67)
- Prolonged detection of indigenous wild polioviruses in sewage from communities in Egypt. (2003) (66)
- Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. (1994) (65)
- Multifacility Outbreak of Middle East Respiratory Syndrome in Taif, Saudi Arabia (2016) (65)
- Oral polio vaccine response in breast fed infants with malnutrition and diarrhea. (2014) (65)
- [46] Preparation and characterization of encephalornyocarditis (EMC) virus (1981) (65)
- Isolation of recombinant type 2 vaccine-derived poliovirus (VDPV) from a Nigerian child. (2007) (64)
- Modeling Population Immunity to Support Efforts to End the Transmission of Live Polioviruses (2013) (63)
- Serologic response to inactivated poliovirus vaccine: a randomized clinical trial comparing 2 vaccination schedules in Puerto Rico. (2007) (62)
- Defining Surrogate Serologic Tests with Respect to Predicting Protective Vaccine Efficacy: Poliovirus Vaccination (1995) (61)
- Monovalent type 1 oral poliovirus vaccine in newborns. (2008) (60)
- Pathologic studies of fatal cases in outbreak of hand, foot, and mouth disease, Taiwan. (2001) (60)
- Containment of Polioviruses After Eradication and OPV Cessation: Characterizing Risks to Improve Management (2006) (59)
- Evaluation of Response Scenarios to Potential Polio Outbreaks Using Mathematical Models (2006) (58)
- Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication. (2014) (57)
- Increase in Acute Flaccid Myelitis — United States, 2018 (2018) (57)
- Synthesis and Processing of Picornaviral Polyprotein (1979) (57)
- Genomic evidence that simian virus 2 and six other simian picornaviruses represent a new genus in Picornaviridae. (2003) (57)
- Modeling options to manage type 1 wild poliovirus imported into Israel in 2013. (2015) (56)
- What we are watching—five top global infectious disease threats, 2012: a perspective from CDC’s Global Disease Detection Operations Center (2013) (55)
- Diversity of picornaviruses in rural Bolivia. (2013) (55)
- Molecular epidemiology and type-specific detection of echovirus 11 isolates from the Americas, Europe, Africa, Australia, southern Asia and the Middle East. (2003) (54)
- Coxsackievirus B epidemiology and public health concerns. (1997) (54)
- Optimal vaccine stockpile design for an eradicated disease: application to polio. (2010) (52)
- Preeradication Vaccine Policy Options for Poliovirus Infection and Disease Control (2013) (52)
- New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. (1997) (52)
- Isolation of Sabin-Like Polioviruses from Wastewater in a Country Using Inactivated Polio Vaccine (2008) (51)
- Poliovirus vaccination options for achieving eradication and securing the endgame. (2013) (51)
- In Vitro Antiviral Activity of V-073 against Polioviruses (2009) (50)
- Emergence of echovirus type 13 as a prominent enterovirus. (2004) (49)
- The potential impact of expanding target age groups for polio immunization campaigns (2014) (49)
- Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination (2015) (49)
- Environmental surveillance of wild poliovirus circulation in Egypt--balancing between detection sensitivity and workload. (2005) (48)
- Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. (2001) (48)
- Specific detection of echoviruses 22 and 23 in cell culture supernatants by RT‐PCR (1999) (47)
- An outbreak of concurrent echovirus 30 and coxsackievirus A1 infections associated with sea swimming among a group of travelers to Mexico. (2008) (46)
- Echovirus 30 infection and aseptic meningitis in parents of children attending a child care center. (1994) (45)
- Health Care Worker Contact with MERS Patient, Saudi Arabia (2014) (45)
- Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule. (2017) (45)
- Preparation and characterization of encephalomyocarditis (EMC) virus. (1981) (45)
- Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs (2015) (44)
- Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method (2004) (43)
- Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame (2016) (43)
- Coxsackievirus B2 infection and aseptic meningitis: a focal outbreak among members of a high school football team. (1993) (41)
- Global Surveillance and the Value of Information: The Case of the Global Polio Laboratory Network (2006) (41)
- Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication (2017) (41)
- Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus (1980) (40)
- Histopathologic, immunohistochemical, and polymerase chain reaction assays in the study of cases with fatal sporadic myocarditis. (2007) (40)
- Update on the Epidemiology of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection, and Guidance for the Public, Clinicians, and Public Health Authorities — January 2015 (2015) (40)
- Uncertainty and Sensitivity Analyses of a Decision Analytic Model for Posteradication Polio Risk Management (2008) (40)
- Serotype-specific identification of enterovirus 71 by PCR. (2000) (39)
- Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination. (2014) (39)
- Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions. (2011) (38)
- Oligonucleotide probes for the specific detection of the wild poliovirus types 1 and 3 endemic to Brazil. (1991) (37)
- Acute Flaccid Myelitis in the United States: 2015–2017 (2019) (36)
- Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral polio vaccine. (1991) (35)
- Emergence of Vaccine-derived Polioviruses, Democratic Republic of Congo, 2004–2011 (2013) (35)
- An outbreak of acute haemorrhagic conjunctivitis in Melaka, Malaysia. (2003) (35)
- Increased detections and severe neonatal disease associated with coxsackievirus B1 infection--United States, 2007. (2008) (35)
- Complete genome sequences for nine simian enteroviruses. (2007) (35)
- Chronic group A coxsackievirus infection in agammaglobulinemia: demonstration of genomic variation of serotypically identical isolates persistently excreted by the same patient. (1988) (34)
- Dominant drug targets suppress the emergence of antiviral resistance (2014) (34)
- Picornaviral VPg sequences are contained in the replicase precursor (1980) (34)
- Enterovirus molecular detection and typing (2005) (34)
- Polio Eradicators Use Integrated Analytical Models to Make Better Decisions (2015) (33)
- Establishing Evidence for Enterovirus Infection in Chronic Disease (2003) (32)
- High degree of genetic diversity of non-polio enteroviruses identified in Georgia by environmental and clinical surveillance, 2002-2005. (2010) (32)
- CDC's Early Response to a Novel Viral Disease, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), September 2012–May 2014 (2015) (32)
- Multiplex PCR Method for Identifying Recombinant Vaccine-Related Polioviruses (2004) (32)
- Coxsackievirus B3 clinical isolates and murine myocarditis. (1996) (32)
- Acute Flaccid Paralysis from Echovirus Type 33 Infection (2003) (32)
- An outbreak of wild poliovirus in the Republic of Congo, 2010-2011. (2012) (32)
- The role of supplementary environmental surveillance to complement acute flaccid paralysis surveillance for wild poliovirus in Pakistan – 2011–2013 (2017) (32)
- Imported vaccine-associated paralytic poliomyelitis--United States, 2005. (2006) (31)
- Geographical genotypes (geotypes) of poliovirus case isolates from the former Soviet Union: relatedness to other known poliovirus genotypes. (1995) (31)
- Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire. (2005) (31)
- Trends in the Risk of U.S. Polio Outbreaks and Poliovirus Vaccine Availability for Response (2012) (31)
- Global Transmission of Live Polioviruses: Updated Dynamic Modeling of the Polio Endgame (2020) (31)
- First Confirmed Cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, Updated Information on the Epidemiology of MERS-CoV Infection, and Guidance for the Public, Clinicians, and Public Health Authorities—May 2014 (2014) (31)
- Sites other than nucleotide 234 determine cardiovirulence in natural isolates of coxsackievirus B3 (1997) (31)
- Molecular Epidemiology and Genetic Diversity of Echovirus Type 30 ( E 30 ) : Genotypes Correlate with Temporal Dynamics of E 30 Isolation (1999) (30)
- Distribution of wild type 1 poliovirus genotypes in China. (1993) (30)
- Type-Specific Detection of Echovirus 30 Isolates Using Degenerate Reverse Transcriptase PCR Primers (2001) (30)
- Switch from oral to inactivated poliovirus vaccine in Yogyakarta Province, Indonesia: summary of coverage, immunity, and environmental surveillance. (2014) (29)
- Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems (2017) (28)
- Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine. (1993) (28)
- Outbreak of echovirus 11 infection in hospitalized neonates. (1988) (27)
- Molecular Epidemiology of Wild Poliovirus Transmission (1990) (27)
- Viral meningitis in child care center staff and parents: an outbreak of echovirus 30 infections. (1999) (27)
- Breaking the Last Chains of Poliovirus Transmission: Progress and Challenges in Global Polio Eradication. (2018) (27)
- Naturally Acquired Picornavirus Infections in Primates at the Dhaka Zoo (2012) (27)
- Survey of poliovirus antibodies during the final stage of polio eradication in Egypt. (2007) (26)
- Increased immunogenicity of oral poliovirus vaccine administered in mass vaccination campaigns compared with the routine vaccination program in Jordan. (1997) (25)
- Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya (2009) (25)
- The Global Polio Laboratory Network as a Platform for the Viral Vaccine-Preventable and Emerging Diseases Laboratory Networks (2017) (25)
- Epidemiology of Group B Coxsackieviruses (1988) (25)
- Updated Characterization of Post‐OPV Cessation Risks: Lessons from 2019 Serotype 2 Outbreaks and Implications for the Probability of OPV Restart (2020) (24)
- Characterization of Poliovirus Variants Selected for Resistance to the Antiviral Compound V-073 (2012) (24)
- Vaccine-associated paralytic poliomyelitis. (1993) (23)
- Survey of poliovirus antibodies in Kano, Northern Nigeria. (2014) (23)
- Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations (2018) (23)
- Outbreak of paralytic poliomyelitis in a highly immunized population in Jordan. (1997) (23)
- Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity (1989) (23)
- Updated Characterization of Outbreak Response Strategies for 2019–2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain (2020) (23)
- Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation. (2016) (22)
- Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria (2015) (22)
- An echovirus type 33 winter outbreak in New Zealand. (2003) (22)
- Shedding of Vaccine Viruses with Increased Antigenic and Genetic Divergence after Vaccination of Newborns with Monovalent Type 1 Oral Poliovirus Vaccine (2009) (22)
- Monovalent type 1 oral poliovirus vaccine among infants in India: report of two randomized double-blind controlled clinical trials. (2011) (21)
- Certifying the interruption of wild poliovirus transmission in the WHO African region on the turbulent journey to a polio-free world (2020) (21)
- Development of an Efficient Entire-Capsid-Coding-Region Amplification Method for Direct Detection of Poliovirus from Stool Extracts (2014) (21)
- Reemergence of an epidemic coxsackievirus B5 genotype. (1987) (21)
- Development and Consideration of Global Policies for Managing the Future Risks of Poliovirus Outbreaks: Insights and Lessons Learned Through Modeling (2006) (20)
- Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial. (2015) (20)
- Zinc supplementation fails to increase the immunogenicity of oral poliovirus vaccine: a randomized controlled trial. (2015) (20)
- Interim CDC Guidance for Polio Vaccination for Travel to and from Countries Affected by Wild Poliovirus (2014) (19)
- The impact of disruptions caused by the COVID-19 pandemic on global polio eradication (2021) (19)
- Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial (2019) (18)
- Detection of vaccine-derived polioviruses in Mexico using environmental surveillance. (2014) (18)
- Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Pakistan and Afghanistan (2018) (17)
- Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman. (1997) (17)
- Assessing population immunity in a persistently high-risk area for wild poliovirus transmission in India: a serological study in Moradabad, Western Uttar Pradesh. (2014) (17)
- Randomized trial of type 1 and type 3 oral monovalent poliovirus vaccines in newborns in Africa. (2012) (16)
- An epidemic of acute hemorrhagic conjunctivitis in American Samoa caused by coxsackievirus A24 variant. (1989) (16)
- A theoretical framework for evaluating the sensitivity of surveillance for detecting wild poliovirus: I. Factors affecting detection sensitivity in a person with acute flaccid paralysis. (1997) (16)
- Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010. (2013) (16)
- Aseptic meningitis outbreak associated with echovirus 9 among recreational vehicle campers--Connecticut, 2003. (2004) (15)
- Genotype-specific RNA probes for direct identification of wild polioviruses by blot hybridization (1997) (15)
- Estimating the likely coverage of inactivated poliovirus vaccine in routine immunization: evidence from demographic and health surveys. (2014) (15)
- Updated modelling of the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus (iVDPV) excreters (2019) (14)
- Mechanism of Poliovirus Eradication (2002) (14)
- Identification of an antigenic subtype of eastern equine encephalitis virus isolated from a human (1990) (14)
- A theoretical framework for evaluating the sensitivity of surveillance for detecting wild poliovirus: II. Factors affecting detection sensitivity in a population with circulating wild poliovirus. (1997) (14)
- EVIDENCE FOR A SELF-CLEAVING PRECURSOR OF VIRUS-CODED PROTEASE, RNA-REPLICASE, AND VPg (1980) (14)
- Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States (2017) (14)
- Individual-based modeling of potential poliovirus transmission in connected religious communities in North America with low uptake of vaccination. (2014) (14)
- A world without polio. (2014) (14)
- Ending Use of Oral Poliovirus Vaccine - A Difficult Move in the Polio Endgame. (2018) (13)
- Direct Sequencing of SARS-Coronavirus S and N Genes from Clinical Specimens Shows Limited Variation (2004) (13)
- Acute hemorrhagic conjunctivitis due to enterovirus 70 in American Samoa: serum-neutralizing antibodies and sex-specific protection. (1992) (13)
- Comparison of a monoclonal antibody-based IgM capture ELISA with a neutralization assay for assessing response to trivalent oral poliovirus vaccine. (1997) (12)
- Molecular identification and characterization of two proposed new enterovirus serotypes , EV 74 and EV 75 (2004) (11)
- Characterising the costs of the Global Polio Laboratory Network: a survey-based analysis (2019) (11)
- Notes from the field: acute hemorrhagic conjunctivitis outbreaks caused by coxsackievirus A24v --- Uganda and southern Sudan, 2010. (2010) (10)
- Prevalence of asymptomatic poliovirus infection in older children and adults in northern India: analysis of contact and enhanced community surveillance, 2009. (2014) (10)
- Progress in Vaccine-Preventable and Respiratory Infectious Diseases—First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006–2015 (2018) (9)
- Updated characterization of poliovirus transmission in Pakistan and Afghanistan and the impacts of different outbreak response vaccine options (2021) (9)
- Molecular Detection and Characterization of Human Enteroviruses (2003) (9)
- Diagnosis of enterovirus 70 infection by demonstration of IgM antibodies (1987) (8)
- Phylogeny of imported and reestablished wild polioviruses in theDemocratic Republic of the Congo from 2006 to 2011. (2014) (8)
- Expansion of syndromic vaccine preventable disease surveillance to include bacterial meningitis and Japanese encephalitis: evaluation of adapting polio and measles laboratory networks in Bangladesh, China and India, 2007-2008. (2015) (8)
- Circadian and circannual aspects of the complement cascade - new and old results, differing in specificity. (1980) (8)
- Enterovirus 71 encephalitis: a new vaccine on the horizon? (2013) (8)
- Documentation and verification of measles, rubella and congenital rubella syndrome elimination in the region of the Americas : United States national report, March 28, 2012 (2012) (7)
- Outbreak of type 1 wild poliovirus infection in adults, Namibia, 2006. (2014) (7)
- Outbreak of poliomyelitis in Gizan, Saudi Arabia: cocirculation of wild type 1 polioviruses from three separate origins. (1997) (7)
- The complete genome sequence for an American isolate of enterovirus 77 (2007) (7)
- Outbreak of vertigo in Wyoming: possible role of an enterovirus infection (1996) (7)
- Population Immunity to Polioviruses Among Preschool Children From Four Urban Underserved Low Income Communities, United States, 1997–2001 (2004) (6)
- Effect of time at temperature on wild poliovirus titers in stool specimens. (2015) (6)
- Vaccine-preventable disease susceptibility in a young adult Micronesian population. (1994) (6)
- Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response (2021) (6)
- Chapter 60 – Enterovirus Infections, Including Poliomyelitis (2006) (6)
- Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial. (2018) (6)
- Effect of buffer on the immune response to trivalent oral poliovirus vaccine in Bangladesh: a community based randomized controlled trial. (2014) (5)
- Enteroviruses and parechoviruses. (2009) (5)
- Surveillance during an era of rapidly changing poliovirus epidemiology in India: the role of one vs. two stool specimens in poliovirus detection, 2000–2010 (2013) (5)
- Quantitative determination of α-tocopherol on thin layers of silica gel (1977) (5)
- Immune Priming and Long-term Persistence of Memory B Cells After Inactivated Poliovirus Vaccine in Macaque Models: Support for at least 2 Doses (2018) (5)
- Poliomyelitis-related case-fatality ratio in India, 2002-2006. (2011) (4)
- Modeling Poliovirus Transmission in Borno and Yobe, Northeast Nigeria (2020) (4)
- The Long and Winding Road to Eradicate Vaccine-Related Polioviruses. (2020) (3)
- Neutralization capacity of highly divergent type 2 vaccine-derived polioviruses from immunodeficient patients. (2020) (3)
- Progress Toward Poliovirus Containment Implementation — Worldwide, 2019–2020 (2020) (3)
- Outbreak response strategies with type 2-containing oral poliovirus vaccines. (2022) (3)
- Acute Hemorrhagic Conjunctivitis in the Western Hemisphere (1980–87) (1989) (3)
- Global oral poliovirus vaccine stockpile management as an essential preparedness and response mechanism for type 2 poliovirus outbreaks following global oral poliovirus vaccine type 2 withdrawal. (2022) (2)
- Coronavirus (MERS-CoV) (2014) (2)
- Using the virus challenge dose in the analysis of virus neutralization assays. (1992) (2)
- [Epidemic outbreak of viral meningitis caused by type 30 ECHO virus]. (1992) (2)
- Janice Dynamics of E 30 Isolation Genotypes Correlate with Temporal Diversity of Echovirus Type 30 ( E 30 ) : Molecular Epidemiology and Genetic (1999) (2)
- Molecular epidemiology of wild poliovirus type 1 circulation in West and Central Africa, from 1997 to 1999, using genotyping with a restriction fragment length polymorphism assay (2007) (2)
- Immunoglobulin class and subclass-specific monoclonal antibody sandwich ELISA for the detection of antibodies against coxsackieviruses B, types 1-5. (1992) (2)
- Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trial. (2021) (2)
- Circulating vaccine-derived polioviruses: current state of (2004) (1)
- Circulating Poliovirus in New York - New Instance of an Old Problem. (2022) (1)
- Health Care Worker Contact with MERS Patient (2014) (1)
- Juvenile Dermatomyositis at Onset: Demographics, Clinical Characteristics, and Access to Care. ♦ 1844 (1997) (1)
- Quantitative determination of alpha-tocopherol on thin layers of silica gel. (1977) (1)
- No longterm oral polio vaccine virus persistence after its removal from the immunisation schedule in New Zealand (2005) (1)
- Erratum to “Serotype-specific identification of enterovirus 71 by PCR”: [JCV 16 (2000) 107–112] (2002) (1)
- Fatal Encephalitis In Young Children, Taiwan, 1998 (1999) (1)
- COMMON INFECTIONS AND UNCOMMON DISEASE: ELUSIVE ASSOCIATIONS OF ENTEROVIRUSES AND TYPE I DIABETES MELLITUS (2004) (1)
- Modeling Poliovirus Surveillance and Immunization Campaign Quality Monitoring Costs for Pakistan and Afghanistan for 2019-2023. (2021) (1)
- An outbreak of echovirus type 33 infection in New Zealand 2000 (2001) (0)
- PXII-8 Molecular characterization of human parechoviruses (HPEV) associated with sudden infant deaths in Wisconsin (2009) (0)
- syndrome coronavirus (MERS-CoV) into the United States (2014) (0)
- Molecular Epidemiology and Evolution of Enterovirus 71 Strains Isolated from 1970 to 1998 (2000) (0)
- during Widespread Circulation in China Wild-Vaccine Poliovirus Recombinant Molecular Evolution of a Type 1 (2000) (0)
- deoxyinosine residue at positions of codon PCR using primers containing mixed-base or Group-specific identification of polioviruses (1996) (0)
- Table of Contents. (2017) (0)
- Poliovirus Eradication Campaign: Progress and Challenges (2016) (0)
- Detection of dengue virus NS1 provides early diagnosis and is a prognostic marker of disease progression (2003) (0)
- CHARACTERIZING ENTEROVIRUS TRANSMISSION BETWEEN HUMANS AND PRIMATES IN BANGLADESH (2007) (0)
- Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems (2017) (0)
- Identification ofan Antigenic Subtype ofEastern Equine Encephalitis Virus Isolated froma Human (1990) (0)
- Acute Flaccid Myelitis - Epidemiology and Clinical Characteristics, United States, August 2014 – August 2017 (P6.421) (2018) (0)
- Outbreak ofvertigo inWyoming: possible roleofan enterovirus infection (1996) (0)
- Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020. (2023) (0)
- Vanquishing the Terror of Poliomyelitis (2005) (0)
- Cell-free synthesis and processing of the proteins of poliovirus ( picornavirus / translation / post-translational cleavage / reticulocyte lysate ) (0)
- Author response: Dominant drug targets suppress the emergence of antiviral resistance (2014) (0)
- New Onset Juvenile Dermatomyositis (JDMS): Comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. • 1845 (1997) (0)
- Communicating the Molecular Epidemiology of Poliovirus by Using Geographical Information Systems for the Global Polio Eradication Initiative (2002) (0)
- Erratum to “coxsackievirus B3 clinical isolates and murine myocarditis” [Virus research 41 (1996) 94] ☆ (1996) (0)
- Taxonomy of the Picornaviridae: Expanding the Family Beyond 12 Genera (2010) (0)
- OPV virus circulation and evolution investigated in New Zealand (2003) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mark A. Pallansch?
Mark A. Pallansch is affiliated with the following schools:
